European Healthcare Acquisition & Growth Company B.V.
European Healthcare Acquisition & Growth Company B.V. Fundamental Analysis
European Healthcare Acquisition & Growth Company B.V. (EHCS.AS) shows weak financial fundamentals with a PE ratio of -2.02, profit margin of 0.00%, and ROE of 2.65%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 56.6/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze EHCS.AS's fundamental strength across five key dimensions:
Efficiency Score
WeakEHCS.AS struggles to generate sufficient returns from assets.
Valuation Score
ExcellentEHCS.AS trades at attractive valuation levels.
Growth Score
WeakEHCS.AS faces weak or negative growth trends.
Financial Health Score
ExcellentEHCS.AS maintains a strong and stable balance sheet.
Profitability Score
WeakEHCS.AS struggles to sustain strong margins.
Key Financial Metrics
Is EHCS.AS Expensive or Cheap?
P/E Ratio
EHCS.AS trades at -2.02 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, EHCS.AS's PEG of -0.02 indicates potential undervaluation.
Price to Book
The market values European Healthcare Acquisition & Growth Company B.V. at 31.91 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -7.68 times EBITDA. This is generally considered low.
How Well Does EHCS.AS Make Money?
Net Profit Margin
For every $100 in sales, European Healthcare Acquisition & Growth Company B.V. keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $2.65 in profit for every $100 of shareholder equity.
ROA
European Healthcare Acquisition & Growth Company B.V. generates $-1.89 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.29 in free cash annually.
FCF Yield
EHCS.AS converts -2.71% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-2.02
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.02
vs 25 benchmark
P/B Ratio
Price to book value ratio
31.91
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.14
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
2.65
vs 25 benchmark
ROA
Return on assets percentage
-1.89
vs 25 benchmark
ROCE
Return on capital employed
-5.35
vs 25 benchmark
How EHCS.AS Stacks Against Its Sector Peers
| Metric | EHCS.AS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -2.02 | 18.59 | Better (Cheaper) |
| ROE | 265.36% | 801.00% | Weak |
| Net Margin | 0.00% | -498.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.98 | Strong (Low Leverage) |
| Current Ratio | 1.14 | 661.40 | Neutral |
| ROA | -189.47% | -21324.00% (disorted) | Weak |
EHCS.AS outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews European Healthcare Acquisition & Growth Company B.V.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical